Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005006531 | SCV005640999 | uncertain significance | Polycystic kidney disease, adult type | 2024-03-14 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV005006531 | SCV006058170 | uncertain significance | Polycystic kidney disease, adult type | 2024-10-30 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004740141 | SCV005358946 | uncertain significance | PKD1-related disorder | 2024-04-25 | no assertion criteria provided | clinical testing | The PKD1 c.10642C>T variant is predicted to result in the amino acid substitution p.Arg3548Cys. This variant was reported in an individual with autosomal dominant polycystic kidney disease (ADPKD) (Carrera et al. 2016. PubMed ID: 27499327, Suppl. Table S4). This variant is reported in 0.038% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |